Stock Track | Alvotech Soars 6.13% in Pre-Market After Clearing Key FDA Inspection

Stock Track

05/11

Alvotech's stock surged 6.13% in pre-market trading on Monday, following a significant regulatory update from the biosimilar developer.

The price movement comes after the company announced that the U.S. Food and Drug Administration has completed a routine cGMP surveillance inspection of its manufacturing facility in Reykjavik, Iceland. The FDA concluded the inspection and issued a Form 483, but Alvotech stated that the observations can be addressed quickly and do not raise any substantial issues with the site or its operations.

This positive inspection outcome positions Alvotech to resubmit its relevant Biologics License Applications (BLAs) in the current quarter. The company continues to expect FDA approval for these biosimilar candidates during 2026, marking a crucial step forward for its product pipeline.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1168707808"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1168707808\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1168707808?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-11 21:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168707808","market":"nz","top_or_hot":-1,"title":"Stock Track | Alvotech Soars 6.13% in Pre-Market After Clearing Key FDA Inspection","media":"Stock Track","content":"<p>Alvotech's stock surged 6.13% in pre-market trading on Monday, following a significant regulatory update from the biosimilar developer.</p><p>The price movement comes after the company announced that the U.S. Food and Drug Administration has completed a routine cGMP surveillance inspection of its manufacturing facility in Reykjavik, Iceland. The FDA concluded the inspection and issued a Form 483, but Alvotech stated that the observations can be addressed quickly and do not raise any substantial issues with the site or its operations.</p><p>This positive inspection outcome positions Alvotech to resubmit its relevant Biologics License Applications (BLAs) in the current quarter. The company continues to expect FDA approval for these biosimilar candidates during 2026, marking a crucial step forward for its product pipeline.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Alvotech Soars 6.13% in Pre-Market After Clearing Key FDA Inspection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Alvotech Soars 6.13% in Pre-Market After Clearing Key FDA Inspection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-11 21:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alvotech's stock surged 6.13% in pre-market trading on Monday, following a significant regulatory update from the biosimilar developer.</p><p>The price movement comes after the company announced that the U.S. Food and Drug Administration has completed a routine cGMP surveillance inspection of its manufacturing facility in Reykjavik, Iceland. The FDA concluded the inspection and issued a Form 483, but Alvotech stated that the observations can be addressed quickly and do not raise any substantial issues with the site or its operations.</p><p>This positive inspection outcome positions Alvotech to resubmit its relevant Biologics License Applications (BLAs) in the current quarter. The company continues to expect FDA approval for these biosimilar candidates during 2026, marking a crucial step forward for its product pipeline.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALVO","symbol_name":"Alvotech","start_time":0,"source_url":"","article_id":"1168707808","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168707808","pubTimestamp":1778505177,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Alvotech's stock surged 6.13% in pre-market trading on Monday, following a significant regulatory update from the biosimilar developer.The price movement comes after the company announced that the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ALVO":"Alvotech"},"translate_title":"个股追踪|Alvotech通过FDA关键检查后盘前大涨6.13%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALVO":1},"content_text":"Alvotech's stock surged 6.13% in pre-market trading on Monday, following a significant regulatory update from the biosimilar developer.The price movement comes after the company announced that the U.S. Food and Drug Administration has completed a routine cGMP surveillance inspection of its manufacturing facility in Reykjavik, Iceland. The FDA concluded the inspection and issued a Form 483, but Alvotech stated that the observations can be addressed quickly and do not raise any substantial issues with the site or its operations.This positive inspection outcome positions Alvotech to resubmit its relevant Biologics License Applications (BLAs) in the current quarter. The company continues to expect FDA approval for these biosimilar candidates during 2026, marking a crucial step forward for its product pipeline.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}